YMAB ymabs.com Company Cash on Hand

Official company branding of YmAbs (YMAB)

Y-mAbs Therapeutics implements precision antibodies and radioimmunotherapy to combat rare forms of cancer. The size of the cash position confirms financial stability, with the metric holding at 0.06. Revenues are based on the commercialization of Danyelza and the development of the radiopharmaceutical pipeline. High physician confidence underscores the brand's ethical status in the field of pediatric oncology.

Y-mAbs Therapeutics Inc - YMAB Company Total Cash Amount (period 07/04/2022 - 09/27/2025)

Summary analytical data breakdowns for Y-mAbs Therapeutics Inc (YMAB)

- stock value and consensus price forecast:
Fundamental valuation:Y-mAbs Corp
Brand item of Y-mAbs Therapeutics, Inc.

This indicator captures the aggregate balance of liquid assets at the end of the reporting period, determining the business's ability to promptly meet its obligations. The metric measures the cash reserves available to cover operating expenses without resorting to external financing. For Y-mAbs Therapeutics (YMAB), this resource is critical for maintaining dominance in pediatric immuno-oncology and protecting patent advantages. The trend in high-liquid cash volumes allows for an assessment of the capital burn rate in an environment devoid of price competition.

Analysis of competing companies

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|CGON - Company Cash Funds|Company Total Cash Volume URGN|BCAX: Company Cash Volume|PSNL - Company Liquid Assets|ERAS (Erasca Inc) - Company Cash Volume|Company Cash Reserve Delcath Systems Inc DCTH|Company Cash Volume AURA|CADL (Candel Therapeutics, Inc.) - Company Cash Balance|Company Cash Funds Accuray Inc ARAY|Company Liquid Assets SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Company Cash Volume|Company Cash Reserve Citius Oncology|HURA: Company Cash Volume|Company Total Cash Volume TARA (Protara)|FATE (fatetherapeutics.com) - Company Cash Volume|Company Cash Reserve Aadi Bioscience WHWK|Company Cash Volume TCRX|CSBR - Company Cash Reserve|XBiotech - Company Cash on Hand|CEL-SCI Corporation (CVM) - Company Cash Reserve|OSTX - Company Cash Funds|Company Cash Reserve Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Company Cash on Hand|ANL (Adlai Nortye Ltd) - Company Cash Funds|Company Cash on Hand VERU|Tempest Therapeutics (TPST) - Company Liquid Assets|Company Cash Volume XLO|Company Cash on Hand Renovaro RENB|Company Cash Volume MURA (Mural Oncology PLC)|KAPA - Company Cash on Hand|OnKure Therapeutics - Company Cash Volume|w2.cytomed.sg - Company Total Cash Amount|Curis Corp (CRIS) - Company Cash Funds|Company Cash Reserve Apollomics Corp (APLM)|Company Cash Funds Tharimmune|Company Cash Volume advanbiomed.com|Company Cash Funds Genprex, Inc (GNPX)|Company Liquid Assets Calidi Biotherapeutics, Inc.|Company Cash Volume SBFM (Sunshine Biopharma Inc.)|XBIO - Company Cash on Hand|SLRX: Company Cash on Hand|Company Cash Balance PPBT (Purple Biotech Ltd.)|AONC: Company Cash Volume|Company Cash Reserve BeOne Medicines (BGNE)|Company Cash Funds Checkpoint Therapeutics, Inc.|Company Cash on Hand Elevation Oncology (ELEV)|Company Cash Funds iCAD Corp (ICAD)|Company Cash on Hand Ikena IKNA|Company Cash Volume NTBL (notablelabs.com)|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds